- Nachrichtendetail
-
01.04.2024 14:15:09 - dpa-AFX: *VERTEX ADVANCES INAXAPLIN INTO PHASE 3 PORTION OF PHASE 2/3 TRIAL FOR TREATMENT OF APOL1-MEDIATED KIDNEY DISEASE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
VERTEX PHARMAC. DL-,01 | 882807 | Xetra | 426,650 | 03.06.24 09:07:42 | +19,650 | +4,83% | 420,950 | 424,300 | 426,650 | 407,000 |
